165 related articles for article (PubMed ID: 31639426)
21. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE
J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828
[TBL] [Abstract][Full Text] [Related]
22. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
[TBL] [Abstract][Full Text] [Related]
23. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava E; Kawai A; Healey JH; Fligman I; Meyers PA; Huvos AG; Gerald WL; Jhanwar SC; Argani P; Antonescu CR; Pardo-Mindan FJ; Ginsberg J; Womer R; Lawlor ER; Wunder J; Andrulis I; Sorensen PH; Barr FG; Ladanyi M
J Clin Oncol; 1998 Apr; 16(4):1248-55. PubMed ID: 9552022
[TBL] [Abstract][Full Text] [Related]
24. Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Dallmayer M; Li J; Ohmura S; Alba Rubio R; Baldauf MC; Hölting TLB; Musa J; Knott MML; Stein S; Cidre-Aranaz F; Wehweck FS; Romero-Pérez L; Gerke JS; Orth MF; Marchetto A; Kirchner T; Bach H; Sannino G; Grünewald TGP
Cell Death Dis; 2019 Feb; 10(2):116. PubMed ID: 30741933
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
Selvanathan SP; Graham GT; Erkizan HV; Dirksen U; Natarajan TG; Dakic A; Yu S; Liu X; Paulsen MT; Ljungman ME; Wu CH; Lawlor ER; Üren A; Toretsky JA
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1307-16. PubMed ID: 25737553
[TBL] [Abstract][Full Text] [Related]
26. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
29. The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.
Parrish JK; Sechler M; Winn RA; Jedlicka P
Oncogene; 2015 Jan; 34(2):257-62. PubMed ID: 24362521
[TBL] [Abstract][Full Text] [Related]
30. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
31. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1.
Barber-Rotenberg JS; Selvanathan SP; Kong Y; Erkizan HV; Snyder TM; Hong SP; Kobs CL; South NL; Summer S; Monroe PJ; Chruszcz M; Dobrev V; Tosso PN; Scher LJ; Minor W; Brown ML; Metallo SJ; Üren A; Toretsky JA
Oncotarget; 2012 Feb; 3(2):172-82. PubMed ID: 22383402
[TBL] [Abstract][Full Text] [Related]
32. Positive feedback loop of lncRNA LINC01296/miR-598/Twist1 promotes non-small cell lung cancer tumorigenesis.
Xu L; Wei B; Hui H; Sun Y; Liu Y; Yu X; Dai J
J Cell Physiol; 2019 Apr; 234(4):4563-4571. PubMed ID: 30240003
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
Theisen ER; Pishas KI; Saund RS; Lessnick SL
Oncotarget; 2016 Apr; 7(14):17616-30. PubMed ID: 26848860
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
[TBL] [Abstract][Full Text] [Related]
35. EWS-FLI1 positively regulates autophagy by increasing ATG4B expression in Ewing sarcoma cells.
Lu Q; Zhang Y; Ma L; Li D; Li M; Li J; Liu P
Int J Mol Med; 2017 Oct; 40(4):1217-1225. PubMed ID: 28902354
[TBL] [Abstract][Full Text] [Related]
36. Pathogenetic implications of early growth response 1 in Ewing sarcoma.
Noh BJ; Jung WW; Kim HS; Park YK
Pathology; 2019 Oct; 51(6):605-609. PubMed ID: 31466866
[TBL] [Abstract][Full Text] [Related]
37. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
[TBL] [Abstract][Full Text] [Related]
38. Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.
Lin L; Huang M; Shi X; Mayakonda A; Hu K; Jiang YY; Guo X; Chen L; Pang B; Doan N; Said JW; Xie J; Gery S; Cheng X; Lin Z; Li J; Berman BP; Yin D; Lin DC; Koeffler HP
Nucleic Acids Res; 2019 Feb; 47(3):1255-1267. PubMed ID: 30496486
[TBL] [Abstract][Full Text] [Related]
39. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
40. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1.
Wei LQ; Li L; Lu C; Liu J; Chen Y; Wu H
J Cell Physiol; 2019 Apr; 234(4):5153-5162. PubMed ID: 30362512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]